Cargando…

Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020

BACKGROUND: In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new co...

Descripción completa

Detalles Bibliográficos
Autores principales: Halatoko, Wemboo Afiwa, Konu, Yao Rodion, Gbeasor-Komlanvi, Fifonsi Adjidossi, Sadio, Arnold Junior, Tchankoni, Martin Kouame, Komlanvi, Koffi Segbeaya, Salou, Mounerou, Dorkenoo, Ameyo Monique, Maman, Issaka, Agbobli, Amétépé, Wateba, Majesté Ihou, Adjoh, Komi Séraphin, Goeh-Akue, Edem, Kao, Yem-bla, Kpeto, Innocent, Pana, Paul, Kinde-Sossou, Rebecca, Tamekloe, Agbeko, Nayo-Apétsianyi, Josée, Assane, Simon-Pierre Hamadi, Prine-David, Mireille, Awoussi, Sossinou Marcel, Djibril, Mohaman, Mijiyawa, Moustafa, Dagnra, Anoumou Claver, Ekouevi, Didier Koumavi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652308/
https://www.ncbi.nlm.nih.gov/pubmed/33166369
http://dx.doi.org/10.1371/journal.pone.0242124
_version_ 1783607685180030976
author Halatoko, Wemboo Afiwa
Konu, Yao Rodion
Gbeasor-Komlanvi, Fifonsi Adjidossi
Sadio, Arnold Junior
Tchankoni, Martin Kouame
Komlanvi, Koffi Segbeaya
Salou, Mounerou
Dorkenoo, Ameyo Monique
Maman, Issaka
Agbobli, Amétépé
Wateba, Majesté Ihou
Adjoh, Komi Séraphin
Goeh-Akue, Edem
Kao, Yem-bla
Kpeto, Innocent
Pana, Paul
Kinde-Sossou, Rebecca
Tamekloe, Agbeko
Nayo-Apétsianyi, Josée
Assane, Simon-Pierre Hamadi
Prine-David, Mireille
Awoussi, Sossinou Marcel
Djibril, Mohaman
Mijiyawa, Moustafa
Dagnra, Anoumou Claver
Ekouevi, Didier Koumavi
author_facet Halatoko, Wemboo Afiwa
Konu, Yao Rodion
Gbeasor-Komlanvi, Fifonsi Adjidossi
Sadio, Arnold Junior
Tchankoni, Martin Kouame
Komlanvi, Koffi Segbeaya
Salou, Mounerou
Dorkenoo, Ameyo Monique
Maman, Issaka
Agbobli, Amétépé
Wateba, Majesté Ihou
Adjoh, Komi Séraphin
Goeh-Akue, Edem
Kao, Yem-bla
Kpeto, Innocent
Pana, Paul
Kinde-Sossou, Rebecca
Tamekloe, Agbeko
Nayo-Apétsianyi, Josée
Assane, Simon-Pierre Hamadi
Prine-David, Mireille
Awoussi, Sossinou Marcel
Djibril, Mohaman
Mijiyawa, Moustafa
Dagnra, Anoumou Claver
Ekouevi, Didier Koumavi
author_sort Halatoko, Wemboo Afiwa
collection PubMed
description BACKGROUND: In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country. OBJECTIVE: This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lomé. MATERIALS AND METHODS: From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests. RESULTS: A total of 955 participants with a median age of 36 (IQR 32–43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3–1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4–1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9–2.6%. CONCLUSION: The prevalence of SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening.
format Online
Article
Text
id pubmed-7652308
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-76523082020-11-18 Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020 Halatoko, Wemboo Afiwa Konu, Yao Rodion Gbeasor-Komlanvi, Fifonsi Adjidossi Sadio, Arnold Junior Tchankoni, Martin Kouame Komlanvi, Koffi Segbeaya Salou, Mounerou Dorkenoo, Ameyo Monique Maman, Issaka Agbobli, Amétépé Wateba, Majesté Ihou Adjoh, Komi Séraphin Goeh-Akue, Edem Kao, Yem-bla Kpeto, Innocent Pana, Paul Kinde-Sossou, Rebecca Tamekloe, Agbeko Nayo-Apétsianyi, Josée Assane, Simon-Pierre Hamadi Prine-David, Mireille Awoussi, Sossinou Marcel Djibril, Mohaman Mijiyawa, Moustafa Dagnra, Anoumou Claver Ekouevi, Didier Koumavi PLoS One Research Article BACKGROUND: In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country. OBJECTIVE: This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lomé. MATERIALS AND METHODS: From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests. RESULTS: A total of 955 participants with a median age of 36 (IQR 32–43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3–1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4–1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9–2.6%. CONCLUSION: The prevalence of SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening. Public Library of Science 2020-11-09 /pmc/articles/PMC7652308/ /pubmed/33166369 http://dx.doi.org/10.1371/journal.pone.0242124 Text en © 2020 Halatoko et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Halatoko, Wemboo Afiwa
Konu, Yao Rodion
Gbeasor-Komlanvi, Fifonsi Adjidossi
Sadio, Arnold Junior
Tchankoni, Martin Kouame
Komlanvi, Koffi Segbeaya
Salou, Mounerou
Dorkenoo, Ameyo Monique
Maman, Issaka
Agbobli, Amétépé
Wateba, Majesté Ihou
Adjoh, Komi Séraphin
Goeh-Akue, Edem
Kao, Yem-bla
Kpeto, Innocent
Pana, Paul
Kinde-Sossou, Rebecca
Tamekloe, Agbeko
Nayo-Apétsianyi, Josée
Assane, Simon-Pierre Hamadi
Prine-David, Mireille
Awoussi, Sossinou Marcel
Djibril, Mohaman
Mijiyawa, Moustafa
Dagnra, Anoumou Claver
Ekouevi, Didier Koumavi
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
title Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
title_full Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
title_fullStr Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
title_full_unstemmed Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
title_short Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
title_sort prevalence of sars-cov-2 among high-risk populations in lomé (togo) in 2020
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652308/
https://www.ncbi.nlm.nih.gov/pubmed/33166369
http://dx.doi.org/10.1371/journal.pone.0242124
work_keys_str_mv AT halatokowembooafiwa prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT konuyaorodion prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT gbeasorkomlanvififonsiadjidossi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT sadioarnoldjunior prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT tchankonimartinkouame prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT komlanvikoffisegbeaya prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT saloumounerou prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT dorkenooameyomonique prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT mamanissaka prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT agbobliametepe prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT watebamajesteihou prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT adjohkomiseraphin prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT goehakueedem prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT kaoyembla prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT kpetoinnocent prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT panapaul prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT kindesossourebecca prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT tamekloeagbeko prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT nayoapetsianyijosee prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT assanesimonpierrehamadi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT prinedavidmireille prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT awoussisossinoumarcel prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT djibrilmohaman prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT mijiyawamoustafa prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT dagnraanoumouclaver prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT ekouevididierkoumavi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020